Axon Enterprise, Inc $AXON Stock Purchased by International Assets Investment Management LLC

International Assets Investment Management LLC raised its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 9,877.5% in the 3rd quarter, Holdings Channel.com reports. The fund owned 101,172 shares of the biotechnology company’s stock after buying an additional 100,158 shares during the quarter. Axon Enterprise comprises approximately 0.7% of International Assets Investment Management LLC’s investment portfolio, making the stock its 10th biggest position. International Assets Investment Management LLC’s holdings in Axon Enterprise were worth $42,747,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Keel Point LLC grew its holdings in shares of Axon Enterprise by 4.4% during the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock worth $254,000 after purchasing an additional 25 shares in the last quarter. Bridgewater Advisors Inc. increased its position in shares of Axon Enterprise by 4.4% in the second quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock worth $352,000 after purchasing an additional 26 shares during the period. Pinnacle Wealth Planning Services Inc. increased its position in shares of Axon Enterprise by 7.8% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock worth $153,000 after purchasing an additional 26 shares during the period. Roman Butler Fullerton & Co. raised its stake in Axon Enterprise by 2.4% in the first quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock valued at $500,000 after purchasing an additional 30 shares in the last quarter. Finally, 44 Wealth Management LLC raised its stake in Axon Enterprise by 6.0% in the first quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after purchasing an additional 30 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AXON has been the subject of several recent analyst reports. Northland Securities set a $540.00 price objective on shares of Axon Enterprise in a research report on Friday. Northcoast Research raised their target price on shares of Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. Piper Sandler restated an “overweight” rating and issued a $540.00 target price (down from $561.00) on shares of Axon Enterprise in a research report on Friday. UBS Group boosted their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Finally, The Goldman Sachs Group decreased their price objective on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating on the stock in a research note on Monday, September 21st. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $631.35.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded down $69.56 during trading on Friday, reaching $313.00. 5,224,684 shares of the company’s stock were exchanged, compared to its average volume of 975,165. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a 1-year low of $307.00 and a 1-year high of $665.07. The company has a market cap of $25.43 billion, a P/E ratio of 100.32, a PEG ratio of 8.09 and a beta of 1.48. The firm’s 50-day moving average price is $441.53 and its 200 day moving average price is $475.20.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.17). The business had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. Axon Enterprise’s quarterly revenue was up 27.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.17 earnings per share. As a group, research analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
• Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
• Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
• Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement

Insiders Place Their Bets

In other news, CEO Patrick Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares in the company, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,397 shares of company stock worth $21,234,034 in the last ninety days. Insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.